Cotinine Screening Devices Market is reaching a valuation

Dubai, United Arab Emirates, February 1, 2022 (GLOBE NEWSWIRE) – Global cotinine test device market Recorded sales value 429.9 million USD In 2021. The market is expected to expand at a CAGR 4.7% It will grow 1.4X By the end of 2029, sales are expected to be valuable $621.4 million USD

According to a new market research report by Future Market Insights, the global cotinine test device market was valued at approximately $429.9 million in 2021 and is expected to increase at a compound annual growth rate of approximately 4.7% during the forecast period 2022-2029. The report examines the Cotinine Screening Devices Market and provides important insights for the forecast period from 2022-2029.

According to the findings of the report, the global Cotinine Screening Devices market is expected to witness significant growth during the forecast period, which will be triggered by a large number of factors such as the increasing focus on “value-based” healthcare services and the rising demand for efficient screening technologies.

Request a sample report to get comprehensive insights into

data points market insights
Market value 2022 450.3 million US dollars
Market value 2029 $621.4 million USD
CAGR 2022-2029 4.7%
Share of the largest 5 countries 71.9%
The main players The major players in the Cotinine Screening Devices market are Abbott Laboratories, AlcoPro, Jant Pharmacal Corporation, Sinocare Inc. , Mossman Associates, Nano-Ditech Corp, LifeSign LLC, ALFA Scientific, Ameritek USA. Hangzhou Clongene Biotech Co., Ltd. , and Germaine Laboratories, Inc.

Develop markets to reflect new growth possibilities

Regions such as North America and Europe are expected to enjoy significant market share in terms of value. However, developing markets are expected to anticipate profitable growth in the global cotinine testing device market in the forecast period 2022-2029. The explosive rise in workplace screenings is one of the main drivers that are creating new growth alleys for cotinine screening device manufacturers to reap the benefits from it. Economic and technological parity between developing regions with developed regions is another major factor that is estimated to generate consistent sales revenue for market players of cotinine screening devices.

Moreover, the high level of awareness and adoption of beneficial products in smoking cessation programs is also supporting profitability for developing markets such as China, India and Brazil. Factors such as the increasing prevalence of smoking, screening of employees for illegal drugs, sporting events, and health plan premium setting are expected to increase sales of cotinine screening devices in developing counties.

A growing middle-class population combined with the many compliance processes created for recruitment into the armed forces are expected to increase potential use cases for cotinine screens in 2022 and beyond. Contract manufacturing services available in developing markets coupled with cheap manpower are expected to enhance the investment quotient and attractiveness of developing countries, making them not less than hotbeds of growth opportunities.

For any inquiries related to the report, ask @analyst.

Report scope

The qualities details
prediction period 2022-2029
Historical data available for 2014-2021
market analysis Million dollars for the value
Main countries covered United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC countries, Turkey, South Africa.
Major sectors covered Device type, sample type, end user and region
An overview of the main companies • Abbott Laboratories
• AlcoPro Inc.
• Gantt Pharmacal Corporation
• Sinocare Inc. , (PTS Diagnostics)
• Mosman Associates
• Nano-Ditech Corp
• LifeSign LLC
• Alpha Scientific
• Ameritech USA.
• Hangzhou Clongene Biotech Co., Ltd.
• Germaine Laboratories, Inc.
Report coverage Market forecast, competition intelligence, DROT analysis, market dynamics and challenges, strategic growth initiatives

End users must show specific preferences for tapes

By device type, Cassettes are expected to hold prominent valuable shares in the global Cotinine Screening Devices market. This has resulted in large part from the cost-effectiveness, ease of examination, rapid detection, and portability of the compact cotinine assay devices. The report reviews the prominent players within the Cotinine Screening Devices market, whose success is dependent on their robust portfolios and regional presence.

We provide tailor-made solutions to suit your requirements, customization request @

The global Cotinine Screening Devices market is highly integrated with a large group of players dominating prominent shares in the market. These players offer cotinine testers under their popular brands such as Accutest®, ALERE ISCREEN®, Reditest®, QuickProfile™, NicCheck™ I, DrugCheck® SalivaScan™, TobacAlert® and more. Mergers and acquisitions will remain a key part of the growth and expansion strategies of players in the Cotinine Screening Devices market, largely focusing on creating new business models as well as distribution channels.

Discover ongoing comprehensive coverage of FMI in healthcare

Non-Invasive Blood Sugar Monitoring Devices Market – Diabetes has evolved as a primary healthcare epidemic characterized by high levels of glucose and the leading cause of death worldwide. In 2014, the World Health Organization (WHO) estimated 8.5% of adults had diabetes.

Remote Patient Monitoring Devices Market – Remote patient monitors support the monitoring of a patient’s physical condition. The patient does not need to visit a doctor. Digital technology is used in remote patient monitors to collect health and other medical data for safe transmission to health care providers located in various locations for clinical review.

Point of Care Blood Screening Devices Market – The global point of care blood screening device market is driven by the growing awareness among the population regarding diabetes in adults and children. The main drivers of the market are the increase in the incidence of diabetes and various types of medical examinations.

Radiotherapy locator market – Radiation therapy locator devices are used to locate patients during a radiotherapy session. The patient’s position and immobilization is important during radiotherapy.

Cataract Surgery Devices Market – Cataract surgery is the removal of the cloudy natural lens and its replacement with an artificial lens that helps restore vision to the eye. Without a cataract surgically removed, most cataract patients experience blurred vision, if not complete blindness.

Pathology Devices Market The growing prevalence of chronic diseases, the increase in the elderly population and the active initiatives of the government to regulate preventive measures for infectious diseases have led to the growth of the pathology devices market globally.

Intraosseous Devices Market – Intraosseous infusion is used primarily in pediatric emergency prehospital settings where intravenous fluids and drugs are difficult to deliver. The increasing prevalence of various forms of diseases and the increasing number of painful surgeries are expected to create a demand for these devices in the coming years.

Home Care Medical Device Market – Home care medical devices are designed for use in any environment outside of a professional healthcare facility. The user can be a patient, caregiver, or family member who directly uses the home medical device or provides assistance with the use of the home medical device.

X-Ray positioning devices market is a type of electromagnetic radiation, ranging from 0.01 to 10 nanometers and corresponding to frequencies between 30 petahertz to 30 exahertz. They are vital in the field of medical imaging since Wilhelm Röntgen discovered that they could be used to determine the structure of bone.

EMG Devices Market – EMG devices are strong and flexible enough to be used to re-educate injured muscles, train tense muscles to relax and also train muscles necessary to improve urinary incontinence.

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market information and advisory services, serving clients in more than 150 countries. FMI is headquartered in Dubai, with delivery hubs in the UK, US and India. The latest market research and industry analysis reports from FMI help companies face challenges and make critical decisions with confidence and clarity amidst intense competition. Our customized and syndicated market research reports provide actionable insights that drive sustainable growth. FMI’s expert-led team of analysts constantly track emerging trends and events in a wide range of industries to ensure our clients are prepared for the evolving needs of their clients.


future market insights,
1602-6 Jumeirah Bay Tower X2,
Part Number: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
The United Arab Emirates
For sales inquiries: [email protected]
For media inquiries: [email protected]
Press release source:


Leave a Comment